Patient-Friendly Explanation
Meglitinides are short-acting diabetes tablets taken just before meals to make the pancreas release more insulin. They often cause weight gain of a few kilograms.
Clinical Definition
Repaglinide and nateglinide close ATP-sensitive potassium channels on pancreatic beta cells, producing a rapid, glucose-dependent insulin release. Compensatory hyperinsulinaemia, defensive snacking after mild hypoglycaemia and increased glucose uptake into adipose tissue drive a typical gain of one to three kilograms over a year of therapy, and the effect is amplified when the tablet is taken without a meal or at a dose that overshoots the mealtime glucose load.
Why It Matters
Patients taking a meglitinide who are working on weight loss should raise it with their prescriber rather than stopping the tablet, as alternatives with weight-neutral or weight-losing profiles exist. NuLifeCare Singapore reviews the full medication list at every weight consultation.